Biotest AG, DE0005227235

Biotest AG, DE0005227235

13.10.2017 - 14:40:09

Biotest AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Biotest AG Landsteinerstraße 5 63303 Dreieich Germany 2. Reason for notification X Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights   Other reason: 3. Details of person subject to the notification obligation Name: City and country of registered office: J O Hambro Capital Management Limited LondonUnited Kingdom 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.  5. Date on which threshold was crossed or reached: 12 Oct 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 0.36 % 4.85 % 5.21 % 19785726 Previous notification 4.00 % 1.21 % 5.21 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) DE0005227201 0 71672 0 % 0.36 % Total 71672 0.36 % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % Right to recall lent shares n/a n/a 959592 4.85 %     Total 959592 % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % %       Total % 8. Information in relation to the person subject to the notification obligationX Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).   Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)   9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

13.10.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Biotest AG Landsteinerstraße 5 63303 Dreieich

Germany Internet: http://www.biotest.de   End of News DGAP News Service

618851  13.10.2017 

@ dgap.de